TABLE 1.
Age | Gender | Location | Tumour | Grade | PanTrk | LI (%) | DNA-based mutation | RNA-based mutation | TMB | MSI | NTRK | IDH |
---|---|---|---|---|---|---|---|---|---|---|---|---|
28 | Male | Frontal | Liponeurocytoma | II | Diffuse | 90 | None | SLCO5A1-NTRK2 | low | stable | Detected | Not done |
10 | Male | Posterior fossa | Pilocytic astrocytoma | I | Diffuse | 90 | BRAFV600E/TP53 | None | medium | none | Not detected | Not done |
54 | Male | Parietal | Astrocytoma | IV | No | 0 | IDH1/ATRX/TP53/BCOR/PTCH1 | EGFR amplification | medium | stable | Not detected | mutant |
33 | Male | Frontal | Oligodendroglioma | III | No | 0 | MET | None | medium | stable | Not detected | mutant |
40 | Male | Temporal | Astroblastoma | None | No | 0 | BRAFV600 E | None | low | stable | Not detected | wildtype |
8 | Male | Posterior fossa | Pilocytic astrocytoma | I | No | 0 | None | AUTS2-BRAF/PRKAR2B-BRAF | low | stable | Not detected | Not done |
52 | Male | Frontal | Glioblastoma | IV | Partial | 40 | TERT/PTEN/FGFR4 | AGBL4-NTRK2/BEND5-NTRK2 | low | stable | Detected | wildtype |
53 | Male | Frontal | Glioblastoma | IV | No | 0 | TP53 | None | high | stable | Not detected | wildtype |
4 | Female | Spinal | Pilocytic astrocytoma | I | No | 0 | None | None | medium | none | Not detected | Not done |
62 | Male | Parietal | Glioblastoma | IV | No | 0 | BRAFV600E/TP53/APC | None | low | stable | Not detected | wildtype |
53 | Male | Temporal | Pilocytic astrocytoma | I | Focal | 10 | TERT/ | EGFR amplification/CD4-6 gain | low | stable | Not detected | wildtype |
45 | Female | Parietal | Glioblastoma | IV | Diffuse | 85 | PTEN | CDK6 gain/EGFR amplification | low | stable | Not detected | wildtype |
40 | Male | Posterior fossa | Pilocytic astrocytoma | I | Focal | 8 | BRAFV600 E | None | medium | stable | Not detected | Not done |
6 | Female | Cerebellar | Medulloblastoma | IV | Diffuse | 90 | PTCH1 | CDK6 gain | low | stable | Not detected | Not done |
3 | Female | Frontal | Pilocytic astrocytoma | I | Focal | 10 | None | None | medium | stable | Not detected | Not done |
36 | Male | Lateral ventricle | Central neurocytoma | II | No | 0 | None | None | low | stable | Not detected | Not done |
45 | Male | Temporal | Glioblastoma | IV | No | 0 | TERT | None | medium | stable | Not detected | wildtype |
12 | Female | Posterior fossa | Pilocytic astrocytoma | I | No | 0 | FGFR1 | None | low | stable | Not detected | Not done |
14 | Male | Hypothalamic | Pilocytic astrocytoma | I | No | 0 | BARD1 | KIAA1549-BRAF | low | stable | Not detected | Not done |
64 | Female | Temporal | Glioblastoma | IV | Focal | 10 | ATRX/TERT | None | medium | none | Not detected | wildtype |
51 | Female | Frontal | Astrocytoma | IV | Partial | 45 | PTEN | None | high | stable | Not detected | mutant |
60 | Male | Temporal | Astrocytoma | IV | Partial | 40 | IDH1 | None | medium | none | Not detected | mutant |
51 | Female | Parietal | Astrocytoma | IV | Non | 0 | IDH1 | None | high | stable | Not detected | mutant |
LI, labelling index; TMB, tumour-burden; MSI, microsatellite instability.